Tomas Ohlsson
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research 13
-
- Radiopharmaceutical Chemistry and Applications 29
- Medical Imaging Techniques and Applications 22
- Monoclonal and Polyclonal Antibodies Research 11
- Physiology top 2%
- Alzheimer's disease research and treatments 14
- Otorhinolaryngology top 5%
- Neurology top 5%
-
- Lung Cancer Treatments and Mutations 7
-
- Cancer Immunotherapy and Biomarkers 7
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Oskar HanssonRuben SmithSven‐Erik StrandOlof StrandbergMichael SchöllJan TennvallJonas JögiSebastian Palmqvist
- Journals
- Cancer Biotherapy and Radiopharmaceuticals (8 papers)Alzheimer s & Dementia (5 papers)Clinical Cancer Research (4 papers)
- Partner nations
- SwedenDenmarkUnited States
In The Last Decade
Tomas Ohlsson
89 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 124
- Psychiatry and Mental health 753
- Radiology, Nuclear Medicine and Imaging 1.0k
- Physiology 963
- Otorhinolaryngology 132
- Neurology 213
Countries citing papers authored by Tomas Ohlsson
This map shows the geographic impact of Tomas Ohlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Ohlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Ohlsson more than expected).
Fields of papers citing papers by Tomas Ohlsson
This network shows the impact of papers produced by Tomas Ohlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Ohlsson. The network helps show where Tomas Ohlsson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tomas Ohlsson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 18 | |
| 2 | 2022 | 4 | |
| 3 | 2021 | 26 | |
| 4 | 2020 | 13 | |
| 5 | 2019 | 7 | |
| 6 | 2019 | 11 | |
| 7 | 2019 | 5 | |
| 8 | 2019 | 16 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 23 | |
| 11 | 2018 | 11 | |
| 12 | 2016 | 130 | |
| 13 | 2014 | 7 | |
| 14 | 2012 | 7 | |
| 15 | 2012 | 10 | |
| 16 | 2010 | 13 | |
| 17 | 2003 | 4 | |
| 18 | 2002 | 210 | |
| 19 | Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule | 2001 | 3 |
| 20 | 1992 | 7 |
About Tomas Ohlsson
Tomas Ohlsson is a scholar working on Radiology, Nuclear Medicine and Imaging, Psychiatry and Mental health and Otorhinolaryngology, having authored 91 papers that have together received 2.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (29 papers), Medical Imaging Techniques and Applications (22 papers), Alzheimer's disease research and treatments (14 papers), Dementia and Cognitive Impairment Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Psychiatry and Mental health (753 citations), Radiology, Nuclear Medicine and Imaging (1.0k citations) and Physiology (963 citations). Tomas Ohlsson has collaborated with scholars based in Sweden, Denmark and United States. Frequent co-authors include Oskar Hansson, Ruben Smith, Sven‐Erik Strand, Olof Strandberg, Michael Schöll, Jan Tennvall, Jonas Jögi, Sebastian Palmqvist, Niklas Mattsson and Rik Ossenkoppele. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, Alzheimer s & Dementia, Clinical Cancer Research, Journal of Microwave Power and Electromagnetic Energy and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.